Literature DB >> 21775426

Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Nicholas G Brown1, Dar-Chone Chow, Banumathi Sankaran, Peter Zwart, B V Venkataram Prasad, Timothy Palzkill.   

Abstract

β-Lactamases hydrolyze β-lactam antibiotics to provide drug resistance to bacteria. β-Lactamase inhibitory protein-II (BLIP-II) is a potent proteinaceous inhibitor that exhibits low picomolar affinity for class A β-lactamases. This study examines the driving forces for binding between BLIP-II and β-lactamases using a combination of presteady state kinetics, isothermal titration calorimetry, and x-ray crystallography. The measured dissociation rate constants for BLIP-II and various β-lactamases ranged from 10(-4) to 10(-7) s(-1) and are comparable with those found in some of the tightest known protein-protein interactions. The crystal structures of BLIP-II alone and in complex with Bacillus anthracis Bla1 β-lactamase revealed no significant side-chain movement in BLIP-II in the complex versus the monomer. The structural rigidity of BLIP-II minimizes the loss of the entropy upon complex formation and, as indicated by thermodynamics experiments, may be a key determinant of the observed potent inhibition of β-lactamases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775426      PMCID: PMC3173220          DOI: 10.1074/jbc.M111.265058

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

Review 1.  Beta propellers: structural rigidity and functional diversity.

Authors:  V Fülöp; D T Jones
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

2.  Kinetics of desolvation-mediated protein-protein binding.

Authors:  C J Camacho; S R Kimura; C DeLisi; S Vajda
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

3.  Design of potent beta-lactamase inhibitors by phage display of beta-lactamase inhibitory protein.

Authors:  W Huang; Z Zhang; T Palzkill
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

Review 4.  Class B beta-lactamases: the importance of being metallic.

Authors:  J A Cricco; A J Vila
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

5.  Structure of the SHV-1 beta-lactamase.

Authors:  A P Kuzin; M Nukaga; Y Nukaga; A M Hujer; R A Bonomo; J R Knox
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

6.  Rational design of faster associating and tighter binding protein complexes.

Authors:  T Selzer; S Albeck; G Schreiber
Journal:  Nat Struct Biol       Date:  2000-07

7.  Crystal structure and kinetic analysis of beta-lactamase inhibitor protein-II in complex with TEM-1 beta-lactamase.

Authors:  D Lim; H U Park; L De Castro; S G Kang; H S Lee; S Jensen; K J Lee; N C Strynadka
Journal:  Nat Struct Biol       Date:  2001-10

8.  CENTA as a chromogenic substrate for studying beta-lactamases.

Authors:  C Bebrone; C Moali; F Mahy; S Rival; J D Docquier; G M Rossolini; J Fastrez; R F Pratt; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 9.  Protein folds propelled by diversity.

Authors:  M Paoli
Journal:  Prog Biophys Mol Biol       Date:  2001       Impact factor: 3.667

Review 10.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

View more
  9 in total

1.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

2.  BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).

Authors:  Nicholas G Brown; Dar-Chone Chow; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

3.  Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Kevin E Ruprecht; Timothy Palzkill
Journal:  J Biol Chem       Date:  2013-04-27       Impact factor: 5.157

4.  Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II.

Authors:  Bartlomiej G Fryszczyn; Carolyn J Adamski; Nicholas G Brown; Kacie Rice; Wanzhi Huang; Timothy Palzkill
Journal:  Protein Sci       Date:  2014-07-01       Impact factor: 6.725

5.  Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.

Authors:  David M Boragine; Wanzhi Huang; Lynn H Su; Timothy Palzkill
Journal:  Chembiochem       Date:  2021-12-07       Impact factor: 3.164

6.  Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.

Authors:  Dar-Chone Chow; Kacie Rice; Wanzhi Huang; Robert L Atmar; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2016-10-26       Impact factor: 5.084

7.  Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  BMC Biochem       Date:  2017-03-06       Impact factor: 4.059

Review 8.  Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein.

Authors:  Warawan Eiamphungporn; Nalini Schaduangrat; Aijaz Ahmad Malik; Chanin Nantasenamat
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

9.  Using Coarse-Grained Simulations to Characterize the Mechanisms of Protein-Protein Association.

Authors:  Kalyani Dhusia; Zhaoqian Su; Yinghao Wu
Journal:  Biomolecules       Date:  2020-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.